Achieve Life Sciences
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
22722 29th Dr SE Ste 100, Bothell, Washi...Phone Number
(425) 686-1500Website
www.achievelifesciences.comRevenue
-Stock Symbol
ACHVIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Achieve Life Sciences
Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.Explore more
Achieve Life Sciences Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Achieve Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Achieve Life Sciences
Funding: Get notified immidiatlly once Achieve Life Sciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Achieve Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Achieve Life Sciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Achieve Life Sciences launches new products
Earning: See what the market has to say on Achieve Life Sciences recently announced quarterly report
Check out if Achieve Life Sciences is spiking on competitors!
Achieve Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Achieve Life Sciences
Compare insights from companies similar to Achieve Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Achieve Life Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Achieve Life Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Achieve Life Sciences.
Achieve Life Sciences financials insights
Gather financial insights about Achieve Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$25M
2024
Other Financing Round
$60M
Achieve Life Sciences Tech Stack
A closer look at the technologies used by Achieve Life Sciences
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Achieve Life Sciences News & Media
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
ORCA-OL data complete the clinical evidence package supporting the cytisinicline smoking cessation NDAAchieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
Christopher Martin joins the Board of Directors, with Mark Zappia and Jim Willis joining as Senior Vice President of Commercial and Vice President of Sales, reuniting the team behind the launch of Ohtuvayre®, one of the most successful specialty pharmaceutical launches in recent industry history Christopher Martin joins the Board of Directors, with Mark Zappia and Jim Willis joining as Senior Vice President of Commercial and Vice President of Sales, reuniting the team behind theAchieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates
Closed Private Placement of Up to $354 Million, Including $180 Million Upfront and $174 Million in Milestone-Driven WarrantsAchieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026
SEATTLE and VANCOUVER, British Columbia, May 05, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced it will report its first quarter 2026 financial results and provide a corporate update on Tuesday, May 12, 2026, at 8:30 AM EDT.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Achieve Life Sciences
Sign Up For FreeTo access detailed company insights
Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.... Read More
